Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 8777-8788

  Lim, Yun Sook ^a   Tran, Huong T L ^a   Park, Soo Je ^a   Yim, Seung Ae ^a   Hwang, Soon B ^a  

^a Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE; DNA DIRECTED RNA POLYMERASE III; JUGLONE; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; PEPTIDYLPROLYL ISOMERASE PIN1; RNA POLYMERASE II; SMALL INTERFERING RNA; VIRUS RNA;

ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; GENE SILENCING; HEPATITIS C VIRUS; HOST CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIFE CYCLE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REPLICON; VIRUS REPLICATION;

CELL LINE; GENE SILENCING; HEPACIVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; PEPTIDYLPROLYL ISOMERASE; PROTEIN INTERACTION MAPPING; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 80052288212     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02533-10     Document Type: Article

References (36)

1. Chao, S. H., A. L. Greenleaf, and D. H. Price. 2001. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 29:767-773.
2. Chatterji, U., et al. 2010. HCV resistance to cyclosporinAdoes not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors. J. Hepatol. 53:50-56.
3. Choi, S. H., and S. B. Hwang. 2006. Modulation of the transforming growth factor-beta signal transductionpathway byhepatitis C virus nonstructural 5A protein. J. Biol. Chem. 281:7468-7478.
4. Choi, S. H., S. H. Jeong, and S. B. Hwang. 2007. Large hepatitis delta antigen modulates transforminggrowth factor-beta signaling cascades: implicationof hepatitis delta virus-induced liver fibrosis. Gastroenterology 132:343-357.
5. Fernandes, F., I. U. Ansari, and R. Striker. 2010. Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A. PLoS One 5:e9815.
6. Giannini, C., and C. Brechot. 2003. Hepatitis C virus biology. Cell Death Differ. 10(Suppl. 1):S27-S38.
7. Jeong, S. J., A. Ryo, and N. Yamamoto. 2009. The prolyl isomerase Pin1 stabilizes the humanT-cell leukemia virus type 1 (HTLV-1) Taxoncoprotein and promotes malignant transformation. Biochem. Biophys. Res. Commun. 381:294-299.
8. Kato, T., et al. 2006. Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1:2334-2339.
9. Lindenbach, B. D., and C. M. Rice. 2005. Unravelling hepatitis C virus replication from genome to function. Nature 436:933-938.
10. Liu, Z., F. Yang, J. M. Robotham, and H. Tang. 2009. Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex. J. Virol. 83:6554-6565.
11. Lu, K. P. 2003. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 4:175-180.
12. Lu, K. P., and X. Z. Zhou. 2007. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 8:90-916.
13. Lu, P. J., X. Z. Zhou, Y. C. Liou, J. P. Noel, and K. P. Lu. 2002. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pinl function. J. Biol. Chem. 277:2381-2384.
14. Manders, E. E. M., F. J. Verbeek, and J. A. Aten. 1993. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169:375-382.
15. Moradpour, D., F. Penin, and C. M. Rice. 2007. Replication of hepatitis C virus. Nat. Rev. Microbiol. 5:453-463.
16. Pang, R., et al. 2004. Pin1 overexpression and β-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene 23:4182-4186.
17. Pang, R., et al. 2007. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132:1088-1103.
18. Pang, R. W., et al. 2006. Pin1 expression contributes to hepatic carcinogenesis. J. Pathol. 210:19-25.
19. Park, C. Y., S. H. Choi, and S. B. Hwang. 2009. Nonstructural 5A protein activates β-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J. Hepatol. 51:853-864.
20. Peloponese, J. M., Jr., J. Yasunaga, T. Kinjo, K. Watashi, and K. T. Jeang. 2009. Peptidyl proline cts-ira/îs-isomerase Pin1 interacts with human T-cell leukemia virus type 1 Tax and modulates its activation of NF-kB. J. Virol. 83:3238-3248.
21. Pietschmann, T., et al. 2006. Constructionand characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. U. S. A. 103:7408-7413.
22. Randall, G., et al. 2007. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. U. S. A. 104:12884-12889.
23. Reese, S., et al. 2010. The Pin 1 inhibitor juglone attenuates kidney fibro-genesis via Pin 1-independent mechanisms in the unilateral ureteral occlusion model. Fibrogenesis Tissue Repair 3:1-8.
24. Rippmann, J. F., et al. 2000. Phosphorylation-dependent proline isomeriza-tion catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ 11:409-416.
25. Saitoh, T., et al. 2006. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7:598-605.
26. Scholle, F., et al. 2004. Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcrip-tome and cell cycle association with viral RNA synthesis. J. Virol. 78:15131524.
27. Sumpter, R., Jr., et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
28. Suzuki, T., K. Ishii, H. Aizaki, and T. Wakita. 2007. Hepatitis C viral life cycle. Adv. Drug Deliv. Rev. 59:1200-1212.
29. Watashi, K., et al. 2008. Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. J. Virol. 82:9928-9936.
30. Watashi, K., et al. 2005. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell 19:111-122.
31. Winkler, K. E., K. I. Swenson, S. Kornbluth, and A. R. Means. 2000. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 287:1644-1647.
32. Wulf, G., G. Finn, F. Suizu, and K. P. Lu. 2005. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 7:435-441.
33. Wulf, G. M., et al. 2001. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20:3459-3472.
34. Yaffe, M. B., et al. 1997. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278:1957-1960.
35. Yang, F., et al. 2008. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro. J. Virol. 82:5269-5278.
36. Yun, S. I., Y. J. Choi, B. H. Song, and Y. M. Lee. 2009. 3′ ds-acting elements that contribute to the competence and efficiency of Japanese encephalitis virus genome replication: functional importance of sequence duplications, deletions, and substitutions. J. Virol. 83:7909-7930.